Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622
Titel:
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622
Auteur:
Schott, Anne F. Barlow, William E. Poznak, Catherine H. Van Hayes, Daniel F. Moinpour, Carol M. Lew, Danika L. Dy, Philip A. Keller, Evan T. Keller, Jill M. Hortobagyi, Gabriel N.